A. de Wolf appears as Aschwin de Wolf, a co-author of the 2024 publication, which explicitly discusses aldehyde-stabilized cryopreservation and argues that contemporary structural brain preservation methods merit serious research, indicating public endorsement rather than mere mention.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
The provided evidence includes a 2025 publication related to preservation of cellular structure, but it does not attribute any statement, authorship, or public position on this theory to A. Goldstein. With no direct quote or attributable publication from the person, the record supports silence rather than endorsement, mention, or contradiction.
Alicia Keberle is a named author on the 2025 brain-banking publications, but the available public abstract/title evidence discusses ultrastructural preservation, immunostaining, and mechanical perfusion in postmortem tissue rather than the specific theory that aldehyde-fixed whole brains can be transitioned into cryoprotected subzero storage to preserve long-term morphology and antigenicity. No direct public endorsement, contradiction, or explicit mention of that theory was found in the provided evidence.
Evidence publication IDs: 53249b16-f452-4001-9e97-c3e810c87d57, 651b2c10-523a-4afb-98b1-904f237b959c
The provided public evidence links Andrew McKenzie to Apex Neuroscience research on brain perfusion, fixation, cryoprotectants, and long-term storage strategies, but it does not show him personally endorsing, mentioning, or contradicting the specific theory that aldehyde-based cryopreservation preserves long-term morphology and antigenicity for future studies.
A. Sowa appears publicly as Allison Sowa, a co-author on two 2025 Free Neuropathology papers about immersion/formaldehyde-based brain banking and ultrastructural preservation quality. That publicly connects her to the morphology-preservation topic, but the cited publications do not, from the provided evidence, directly endorse the specific theory's claims about graded cryoprotectant loading, subzero storage, or superior long-term antigenicity preservation.
Evidence publication IDs: 53249b16-f452-4001-9e97-c3e810c87d57, 2896010e-f303-4dbd-a024-79ea80a5a0bd
silent
The public Apex Neuroscience pages associate McKenzie with preservation-procedure research ('McKenzie et al. 2022') and mention integration of perfusion with immersion fixation, but the provided evidence does not show A.T. McKenzie publicly discussing or endorsing the specific theory that aldehyde-fixed brains can be transferred into cryoprotected subzero storage to preserve long-term morphology and antigenicity.
Evidence publication IDs: e91f16a5-c893-4df9-9ab1-351f640b982a, 745cf74c-1ba5-457a-86c0-057c85027854, e964c001-5795-48b1-aa91-faf90e66c191
silent
The cited 2025 paper lists Alyssa Wilson as an author, but its abstract discusses immersion fixation in brain banking and preservation of cellular structure after formaldehyde fixation. It does not publicly address the specific theory about moving aldehyde-fixed whole brains into cryoprotected subzero storage or preserving long-term antigenicity relative to fluid storage.
Evidence publication IDs: 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
The public evidence links A. Zeleznikow-Johnston to structural brain preservation and biostasis discussions, and his May 2025 conference writeup states that chemical fixation methods provide the highest-quality brain preservation available. That is directionally consistent with the theory’s preservation claims, but the provided evidence does not show him explicitly endorsing the specific aldehyde-based cryopreservation proposition about long-term morphology and antigenicity.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
mentions
B. Wróbel is a coauthor of the 2024 review, which publicly discusses fixed tissue cryopreservation with cryoprotectants and cites aldehyde-stabilized cryopreservation as relevant prior work. However, the review emphasizes a limited evidence base for large/whole-brain cryoprotectant perfusion and does not clearly endorse the full theory's stronger claim about long-term antigenicity being better than fluid storage.
Evidence publication IDs: 57d026ff-e43b-4e12-97b6-0072b5b5964c
silent
Claudia De Sanctis appears as an author on the listed 2025 brain-banking publications, but the available evidence describes postmortem tissue preservation quality, perfusion, and immunostaining rather than explicitly endorsing, mentioning, or disputing aldehyde-based cryopreservation of fixed whole brains in subzero cryoprotected storage for long-term morphology/antigenicity preservation.
Evidence publication IDs: 53249b16-f452-4001-9e97-c3e810c87d57, 651b2c10-523a-4afb-98b1-904f237b959c
mentions
The provided evidence links C.S. López to a 2025 publication on preserving cellular structure via immersion fixation in brain banking, which is directly adjacent to the company theory’s morphology-preservation claims. However, there is no direct quote or explicit public statement in the dossier showing clear endorsement of the full aldehyde-based cryopreservation and antigenicity thesis, so this supports mention rather than endorsement or contradiction.
Evidence publication IDs: 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
Emil F. Kendziorra is a co-author of the 2024 Frontiers article, which discusses aldehyde-stabilized cryopreservation and says fixation followed by cryopreservation may help maintain long-term structural stability. However, the publication does not clearly endorse the full specific theory here, especially the claim about preserving antigenicity better than long-term fluid storage.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
mentions
Emil Kendziorra is listed as a coauthor on the 2024 review 'Cryopreservation of brain cell structure: a review,' which publicly discusses cryoprotectant-based brain preservation and notes such approaches can reduce ice damage, but the review is broad and cautious rather than a clear personal endorsement of this specific aldehyde-based theory.
Evidence publication IDs: 57d026ff-e43b-4e12-97b6-0072b5b5964c
mentions
Emma L. Thorn is a named co-author on public publications about brain-tissue cryopreservation and fixation. In the 2024 review on cryopreservation, the paper states that cryoprotectant-based approaches can reduce ice damage but that evidence for larger samples or whole brains is still limited, which is a public discussion of the theory rather than a clear endorsement or contradiction. Her 2025 immersion-fixation paper also publicly discusses preservation of morphology in fixed brain tissue, providing adjacent support context.
Evidence publication IDs: 57d026ff-e43b-4e12-97b6-0072b5b5964c, 2896010e-f303-4dbd-a024-79ea80a5a0bd
silent
Erin S. Stempinski is a listed coauthor on the 2025 paper about immersion formaldehyde fixation in brain banking, but the abstract discusses fixation quality, ultrastructural preservation, and postmortem interval effects, not aldehyde-based cryopreservation, graded cryoprotectant loading, subzero storage, or long-term antigenicity retention. That is public authorship on an adjacent topic, not a public endorsement or contradiction of this specific theory.
Evidence publication IDs: 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
Francesca Minerva is a listed co-author on the 2024 publication, which publicly discusses aldehyde-stabilized cryopreservation, including fixation followed by ethylene glycol cryoprotectant perfusion and its reported structural-preservation results. However, the cited publication does not clearly endorse the narrower claim about improved long-term antigenicity versus fluid storage, so the strongest supported label is mention.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
silent
The only cited public evidence is a 2025 publication on mechanical perfusion assessment and postmortem interval in brain banking. From the title and provided record, it does not publicly address the aldehyde-based cryopreservation theory, its predicted morphology preservation, or antigenicity claims, and no quotes or other public records show a stance from G.A. Taylor.
Evidence publication IDs: 651b2c10-523a-4afb-98b1-904f237b959c
mentions
George M. Church is a co-author of the 2024 Frontiers article, which publicly discusses aldehyde-stabilized cryopreservation and presents it as a method that can preserve brain structure and support long-term preservation research. But the cited publication does not clearly endorse the narrower claim that this approach preserves long-term antigenicity better than fluid storage, so the evidence supports public mention rather than explicit endorsement.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
mentions
John F. Crary is a listed coauthor on the cryopreservation review and the immersion-fixation paper. Those publications publicly discuss cryoprotectant-based brain preservation, structural preservation, and formaldehyde-fixed tissue, but they do not clearly endorse the specific theory that aldehyde-fixed whole brains can later be moved into subzero cryoprotected storage with better long-term antigenicity than fluid storage; the review notes limited evidence for larger samples/whole brains rather than making a strong claim.
Evidence publication IDs: 57d026ff-e43b-4e12-97b6-0072b5b5964c, 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
John F. Crary is publicly listed as a co-author on two 2025 Free Neuropathology papers reporting that immersion formaldehyde fixation can preserve cellular and ultrastructural features in banked brain tissue. That is adjacent to the theory's morphology-preservation claim, but the cited records do not directly address transferring fixed brains into cryoprotected subzero storage or preserving long-term antigenicity, so this is a mention rather than a clear endorsement.
silent
No public quotes, records, or publications were provided linking Jordan Sparks to this theory, so there is no evidence of endorsement, mention, or contradiction.
mentions
J.P. de Magalhães is a co-author on the 2024 publication, which discusses aldehyde-stabilized cryopreservation, graded cryoprotectant loading, and its potential for long-term structural stability. However, the paper does not clearly endorse the narrower claim about preserving long-term antigenicity for future studies, so the evidence supports public mention rather than a direct endorsement.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
publicly endorses
John Smart is a co-author of the 2024 Frontiers article, which explicitly discusses aldehyde-stabilized cryopreservation as a brain-preservation method, notes it met electron-microscopy-based connectome preservation criteria in a pig brain, and states that contemporary structural brain preservation methods deserve serious research. That is a public supportive stance toward the theory, even though antigenicity is not specifically addressed.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
mentions
Jordan S. Sparks is a listed coauthor on both cited publications. The 2024 Frontiers hypothesis paper explicitly discusses aldehyde-stabilized cryopreservation and fluid preservation as candidate brain-preservation methods and argues these methods merit serious research, which is consistent with the theory at a high level. The 2025 Free Neuropathology paper studies postmortem brain perfusion quality using CT imaging and histology, relevant to the proposed mechanism, but neither paper directly endorses the full specific claim about transferring fixed brains from fluid storage into subzero cryoprotected storage to preserve long-term antigenicity better than fluid storage alone.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68, 651b2c10-523a-4afb-98b1-904f237b959c
silent
No public quote, record, or attributed statement from K.D. Slagell is provided. The cited 2024 publication appears to be background literature on fluid preservation in brain banking, not a direct public endorsement, mention, or contradiction by Slagell of this specific aldehyde-based cryopreservation theory.
Evidence publication IDs: 7dac51f5-71ed-40ff-bd71-efcc6ae98148
publicly endorses
K. Farrell is a coauthor on publications that support the core mechanism and expected benefits of aldehyde/fixation-followed cryopreservation. The cryopreservation review states that pre-fixed brain tissue can be cryoprotected, vitrified, and stored long-term, and the fluid-preservation review states that fixed, sufficiently cryoprotected tissue has shown good preservation of morphology and antigenicity for years while also noting long-term aldehyde fluid storage can hinder antigenicity. That is materially supportive of the theory rather than merely incidental mention.
Evidence publication IDs: 57d026ff-e43b-4e12-97b6-0072b5b5964c, 7dac51f5-71ed-40ff-bd71-efcc6ae98148
mentions
Kurt Farrell is a listed co-author on the 2025 paper about banked brain tissue preservation quality. That paper publicly discusses maintained cell morphology and immunostaining/ultrastructural utility in fixed postmortem brain tissue, which overlaps with parts of the theory, but it does not specifically endorse or test aldehyde-based cryoprotectant loading, subzero storage, or superior long-term antigenicity preservation.
Evidence publication IDs: 6732cb7b-aa85-4724-8553-6550e33bc4b4
mentions
Keith Wiley is a coauthor on the 2024 Frontiers article, which discusses aldehyde-stabilized cryopreservation, graded cryoprotectant use, and preserved brain structure, and notes such methods deserve further research. But the cited publication does not clearly state the narrower claim about long-term antigenicity preservation after transfer from fluid storage into subzero cryostorage, so this is best classified as mention rather than explicit endorsement.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
publicly endorses
Michael A. Cerullo is listed as a co-author on the 2024 publication, which explicitly discusses aldehyde-stabilized cryopreservation, says it may help maintain structural stability over the long term, and frames contemporary structural brain preservation methods as deserving serious research effort. That is a public, supportive treatment of the theory’s core premise.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
silent
M. Garrood is a listed author on the cited 2025 brain-banking papers, but those publications discuss immersion fixation, mechanical perfusion, and ultrastructural preservation quality in banked tissue rather than the specific theory of aldehyde-fixed brains being transferred into cryoprotected subzero storage to preserve long-term morphology and antigenicity. No direct public endorsement, mention, or contradiction of that specific cryopreservation theory appears in the provided evidence.
Evidence publication IDs: 651b2c10-523a-4afb-98b1-904f237b959c, 53249b16-f452-4001-9e97-c3e810c87d57, 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
O. Nnadi is a co-author on public 2024 reviews discussing structural brain preservation and cryopreservation. One co-authored hypothesis paper explicitly discusses aldehyde-stabilized cryopreservation, describing it as a method for maintaining structural stability and noting prize-recognized connectome preservation in pig brain, but it does not clearly endorse the narrower claim about long-term antigenicity retention versus fluid storage.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68, 57d026ff-e43b-4e12-97b6-0072b5b5964c
publicly endorses
R. Risco is a named co-author on the 2024 Frontiers article and is listed under author contributions for writing/review/editing. The paper positively presents aldehyde-stabilized cryopreservation as helpful for long-term structural stability and reports it as the only technique shown to preserve a mammalian brain connectome, which is a public endorsement of the core preservation approach. The publication does not specifically discuss long-term antigenicity, so the match is strongest on morphology/structural preservation rather than every detail of the theory.
Evidence publication IDs: 20eeb662-761c-4f67-a17d-0cccd795af68
silent
The provided dossier contains no public quotes from R. Shankar and only one related 2025 publication on immersion fixation/brain banking, with no evidence here that Shankar authored it or publicly linked himself to the specific aldehyde-based cryopreservation theory or its antigenicity claim.
Evidence publication IDs: 2896010e-f303-4dbd-a024-79ea80a5a0bd
mentions
William Janssen is a listed coauthor on two 2025 Free Neuropathology papers about preserving banked brain tissue structure, including immunostaining and ultrastructural quality. Those public records are adjacent to the theory’s morphology-preservation theme, but they do not publicly endorse or directly address the specific aldehyde-plus-cryoprotectant subzero-storage claim or the long-term antigenicity advantage over fluid storage.